Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05796635 · ClinicalTrials.gov registry record · NA
An Investigation Into the Efficacy of Herpecin L at Reducing the Frequency and Severity of Cold Sores
A NA study, sponsored by Focus Consumer Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT05796635 is a NA study that has completed, run by Focus Consumer Healthcare. The registered enrollment target is 80 participants.
The verdict
NCT05796635, a NA study, has completed, sponsored by Focus Consumer Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
Focus Consumer Healthcare has developed Herpecin L. Herpecin L combines many different ingredients hypothesized to promote quick healing and symptom reduction from cold sores.
Interventions
- OTHER Herpecin L
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-01-04 |
| Est. Completion | 2023-02-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05796635
The ClinicalTrials.gov registry entry for NCT05796635 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Focus Consumer Healthcare, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Herpecin L is the first listed.
NCT05796635 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05796635 about?
NCT05796635 is a clinical study titled "An Investigation Into the Efficacy of Herpecin L at Reducing the Frequency and Severity of Cold Sores". Focus Consumer Healthcare has developed Herpecin L. Herpecin L combines many different ingredients hypothesized to promote quick healing and symptom reduction from cold sores.
What is the current status of trial NCT05796635?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2023-01-04. Estimated completion is 2023-02-20.
What interventions are being tested in trial NCT05796635?
The interventions under investigation include: Herpecin L (OTHER).
Who is sponsoring clinical trial NCT05796635?
This trial is sponsored by Focus Consumer Healthcare, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.